Probiota Americas 2023 is calling for submission of abstracts for this year's event. Don’t miss your chance to present!
Organized by the publishers of NutraIngredients-USA.com, the number one daily news service for the dietary supplements and functional food industries, the Probiota Americas will explore the probiotic scientific frontier, its evolution and commercial application in food, supplements and related product areas.
We are particularly interested in reports from human intervention studies and welcome abstracts from those engaged in all aspects of microbiome science in academia, industry and consumer health, particularly those representing successful academia-industry interactions.
All abstract submissions will be reviewed by our Scientific Committee made up of leading experts from the field of microbiome modulation. All accepted abstracts will be invited to present a poster at our event in Chicago., while the winning abstract will be invited to give a presentation during the Probiota Americas, June 14-16, 2023.
Abstracts
Early-phase, novel, or state-of-the-art research or promising ideas covering the following topics are encouraged:
- Host-microbe interactions in health and disease, including preclinical and clinical studies evaluating pre- and probiotic interventions
- Application and development of “-omics” approaches in biomarker discovery, including identification of potential pre- and probiotic strains. Research identifying strain-specific effects of probiotics for health and wellbeing, including mechanism of action and bioactive discovery and isolation
- Early findings from large scale research projects and clinical trials
- Innovations and novel ideas in the areas of production processes, delivery, formulation and shelf-life
- Consumer and market insights, including population research, trends and threats, commercial packaging and marketing
- Human intervention studies
For more information and to download a copy of the abstract guidelines, please click HERE.
Authors of accepted abstracts will be notified in May 2023.